BACK TO TOP
KSE100
165,867.31
-2288.18
(-1.36%)
KSE100PR
49,970.41
-699.15
(-1.38%)
ALLSHR
100,415.11
-1406.14
(-1.38%)
KSE30
49,518.47
-633.14
(-1.26%)
KMI30
237,511.28
-3182.77
(-1.32%)
BKTI
46,185.33
-610.99
(-1.31%)
OGTI
33,929.38
-432.76
(-1.26%)
KMIALLSHR
65,024.26
-881.93
(-1.34%)
PSXDIV20
76,229.20
-967.08
(-1.25%)
UPP9
59,412.61
-725.44
(-1.21%)
NITPGI
44,268.37
-505.99
(-1.13%)
NBPPGI
47,355.01
-647.68
(-1.35%)
MZNPI
29,810.73
-336.78
(-1.12%)
JSMFI
41,950.22
-880.37
(-2.06%)
ACI
21,084.59
-378.78
(-1.76%)
JSGBKTI
69,751.21
-1090.04
(-1.54%)
HBLTTI
19,154.31
02-10-2026
18.54
(0.10%)
MII30
21,513.98
-262.35
(-1.20%)
Liven Pharma Limited
PHARMACEUTICALS
Rs.30.00
-1.14
(-3.66%)
1D
1M
6M
YTD
1Y
3Y
5Y
^ As of Mon, Oct 5, 2026 3:44 PM
REG
DFC
CSF
ODL
Open
30.50
High
31.71
Low
29.31
Volume
21,307
CIRCUIT BREAKER
28.03 — 34.25
DAY RANGE
29.31 — 31.71
52-WEEK RANGE ^
27.82 — 70.68
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
LDCP
31.14
VAR
22.00
HAIRCUT
27.50
P/E Ratio (TTM) **
N/A
1-Year Change * ^
-57.12%
YTD Change * ^
-42.27%

No record found

No record found

No record found

Market data powered by capitalstake.com. Provided by PSX. ** Based on unconsolidated financials
  * Returns not adjusted for payouts
  ^The historical stock prices have been adjusted to reflect stock splits to ensure comparability over time.

Company Profile

BUSINESS DESCRIPTION

Liven Pharma Limited was incorporated in Pakistan as a private Limited Company on October 21, 1991 and was converted into a public limited company on April 30, 1992 under the Companies Ordinance, 1984 (Repealed with the enactment of the Companies Act, 2017). The principal activity of the Company is the manufacturing of pharmaceuticals and allied products.

KEY PEOPLE
Kashif Hussain SiddiquieCEO
Atif Hussain SiddiqiChairman
Muhammad SaeedCompany Secretary
ADDRESS

49-Km, Multan Road, Lahore

WEBSITE

www.liven-pharma.com

REGISTRAR

F.D. Registrar Services SMC (Pvt.) Ltd., 1705,17th Floor, Saima Trade Tower A, I.I. Chundrigar Road, Karachi

AUDITOR

M/s Reanda Haroon Zakaria Aamir Salman Rizwan & Company, Chartered Accountants

Fiscal Year End

June

Equity Profile

Market Cap (000's)
3,391,211.01
Shares
113,040,367
Free Float
11,304,037
Free Float
10.00%

Announcements

Financial Results
Board Meetings
Others
DateTitleDocument
Oct 5, 2026financial results for the Year Ended June 30, 2026 View   PDF
Oct 5, 2026Transmission of Annual Report for the Year Ended June 30, 2026 View   PDF
Apr 29, 2026Financial Results for the 3rd Quarter Ended 31st March 2026 View   PDF
Mar 9, 2026Condensed Interim Financial Statements for the Half Year ended December 31, 2025 (with shariah compliant disclosure) View   PDF
Feb 27, 2026Condensed Interim Financial Statements for the Half Year ended December 31, 2025. View   PDF
DateTitleDocument
Oct 5, 2026Notice of Annual General Meeting
REVISED
View   PDF
Oct 5, 2026Notice of Annual General Meeting
REVOKED
View   PDF
Oct 2, 2026Board meeting in Progress View   
Sep 25, 2026Board Meeting View   PDF
Apr 23, 2026Board Meeting for the 3rd Quarter Financials of 2025-26 View   PDF
DateTitleDocument
Oct 5, 2026Correction Clarification Regarding Annual Report 2026 View   PDF
Aug 27, 2026Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   
Jul 15, 2026Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   
Jul 14, 2026Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   
Jul 14, 2026Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   

Financials

All numbers in thousands (000's) except EPS

Annual
Quarterly
2026202520242023
Sales105,807127,272245,093
Profit after Taxation(31,139)(584,460)41,744(12,327)
EPS(0.28)(7.11)1.04(1.02)
Q3 2026Q2 2026Q1 2026Q3 2025
Sales29,24754,5598,82114,755
Profit after Taxation(3,956)28,210(30,157)(9,621)
EPS(0.03)(0.30)(0.32)(0.10)
Data powered by Capital Stake. To provide comparable data, information might have been standardized. The data presented may therefore differ from issuer's annual report and 'as reported' data should be obtained directly from the source issuer. See the Capital Stake Terms of Use.

Ratios

2026202520242023
Gross Profit Margin (%)25.1814.1125.46
Net Profit Margin (%)(29.43)(459.22)17.03
EPS Growth (%)96.06(781.03)202.3513.56
PEG(1.51)0.010.04(1.06)

Payouts

Financial Reports